We have previously identified a locus on rat chromosome 10 as carrying a major hypertension gene, BP/SP-1. The 100:1 odds support interval for this gene extended over a 35-centimorgan (cM) region of the chromosome that included the angiotensin I-converting enzyme (ACE) locus as demonstrated in a cross between the strokeprone spontaneously hypertensive rat (SHRSPHD) and the normotensive Wistar-Kyoto (WKY-OHD) rat. Here we report on the further characterization of BP/SP-1, using a congenic strain, WKY-1HD. WKY-1HD animals carry a 6-cM chromosomal fragment genotypically identical with SHRSPHD on chromosome 10, 26 cM away from theACE locus. Higher blood pressures in the WKY-1HD strain compared with the WKY-OHD strain, as well as absence of linkage of the chromosome 10 region to blood pressure in an F2 (WKY-IHD X SHRSPHD) population suggested the existence of a quantitative trait locus, termed BP/SP-la, that lies within the SHRSP-congenic region in WKY-1HD. Linkage analysis in the F2 (WKY-OHD X SHRSPHD) cross revealed that BP/SP-la is linked to basal blood pressure, whereas a second locus on chromosome 10, termed BP/SP-lb, that maps closer to the ACE locus cosegregates predominantly with blood pressure after exposure to excess dietary NaCl. Thus, we hypothesize that the previously reported effect ofBP/SP-1 represents a composite phenotype that can be dissected into at least two specific components on the basis of linkage data and congenic experimentation. One of the loci identified, BP/SP-la, represents the most precisely mapped locus affecting blood pressure that has so far been characterized by random-marker genome screening.
of the loci identified, BP/SP-la, represents the most precisely mapped locus affecting blood pressure that has so far been characterized by random-marker genome screening.
Human primary hypertension is one of the most common chronic diseases (1) . It shows a significant degree of heritability (2) (3) (4) and is commonly recognized as a complex, polygenic disorder, with the exception of rare monogenetic forms (5, 6) . The nature of complex disease makes it very difficult to identify contributing genes (7) ; one way to reduce the complexity of this challenge is the use of inbred animal models that exist for a number of human diseases, among them hypertension (8) . Information about genetic factors identified in such experimental systems may provide insights into disease mechanisms that can then be applied to the generation and testing of hypotheses regarding the pathogenesis of the disease in humans.
By using random-marker genetic-screening methods in experimental crosses between the Heidelberg strains of the stroke-prone spontaneously hypertensive rat (SHRSPHD) and the normotensive reference strain Wistar-Kyoto (WKYHD), we previously identified a major quantitative trait locus for blood pressure (9, 10) . The 100:1 odds interval for placing this locus, termed BP/SP-1, mapped to a region of rat chromosome indicate the previously determined 100:1 odds support interval for placement of the blood pressure-relevant gene BP/SP-1 for baseline and NaCl-induced blood pressure, respectively. "-W" denotes markers homologous with WKY-OHD alleles, whereas "-S" identifies markers identical to SHRSPHD alleles, defining the congenic region in WKY-1HD. Recombination distances are given in centimorgans.
10 that spans 35 centimorgans (cM). This region was defined by simple-sequence length polymorphism (SSLP) markers from the genes coding for growth hormone (RNGHGP)I, fast nerve growth factor receptor (RNNGFRR), and myosin heavy chain (RNMHCG). Linkage to BP/SP-1 was highly significant for blood pressure values measured after dietary NaCl loading; the influence of this locus on baseline blood pressure was less significant and mapping therefore was less precise (Fig. 1) .
The linkage group containing these markers on chromosome 10 has been shown to be homologous to a region on human chromosome 17q23 that also carries the angiotensin I-converting enzyme (ACE) gene (12) , an obvious candidate gene for hypertension (13) .
The current set of experiments was aimed at further characterizing the BP/SP-1 locus.
MATERIALS AND METHODS
Animals and Genetic Crosses. All animals were obtained from our colonies of SHRSPHD, WKY-0HD, and WKY-1HD rats at the University of Heidelberg (Heidelberg, Germany) (the subscript indicates this origin). SHRSPHD had been Abbreviations: SSLP, simple-sequence length polymorphism; cM, centimorgan(s). §To whom reprint requests should be addressed.
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Proc. Natl. Acad. Sci. USA 92 (1995) 8779 obtained from the original Japanese stock from Okamoto and Aoki (14) in 1974 and propagated by strict inbreeding. WKY-OHD and WKY-1HD are two lineages of the WKY reference strain, also obtained from the Japanese stock in 1974, that were propagated as parallel families.
The first F2 population used in the present study has been described in detail (15) . All WKY animals that contributed to this cohort (n = 115) were from one WKY-OHD litter, confirmed by genotype analysis. These animals were referred to as "WKY" in previous reports (9, 10, 15) , since at that time the existence of the WKY-1HD strain had not been recognized. For the second F2 population reported in this paper, SHRSPHD rats were crossed with animals from one WKY-1HD litter by following the same reciprocal breeding algorithm used in the previous study (15) , thus generating an F2 (WKY-lHD X SHRSPHD) cohort (n = 139). This F2 population consisted of 33 males and 42 females with an SHRSPHD grandfather and 34 males and 30 females with a WKY-1HD grandfather.
Phenotype Determination. Two different methods for blood pressure determination were used. Femoral artery cannulation and intermittent on-line recordings of tethered F2 rats at baseline and after dietary NaCl loading were identical to the previously employed procedures (15) .
A radiotelemetry method (Data Science International, Minneapolis) which allows highly accurate and reproducible blood pressure determinations was used to characterize parental WKY-OHD (n = 8) and WKY-1HD (n = 9) rats (16) . The protocol for phenotype data sampling included measurements at baseline and after NaCl exposure in animals that were age-matched with the F2 rats previously studied (9, 10) .
DNA Sequencing. Comparative sequencing of genomic DNA from parental rat strains to identify polymorphisms was performed at several loci. PCR-derived amplification products from genomic DNA were used without further subcloning. PCR-amplified templates from each parental strain (WKY-OHD, WKY-1HD, and SHRSPHD) were sequenced in duplicate with Taq dye-primer sequencing kits on an automated 373A DNA sequencer (Applied Biosystems).
Genotype Determination. The majority of polymorphic markers used were SSLPs; a few markers were represented by single base-pair differences (see below). SSLPs were obtained from the panel we used previously (9, 17) (18) . Genotypes were determined by the procedure described above, using primers R422-F (5'-TACATAGTGAATA-AACGGGAGC-3') and R422-R (5'-TCAGGTAGGAGCCT-GAGC-3')-from positions 4371-4392 and 4610-4627, respectively, of the rat genomic sequence (18)-at an annealing temperature of 53°C.
Acetylcholine receptor D subunit (RNACRB1) gene locus. The RNACRB1 gene was partially sequenced after amplification from genomic DNA using primers based on the rat mRNA sequence (11) and with reference to information available on the genomic structure of the mouse gene (19) . By using primers RACRB4-F (5'-GGCGGTCCCCATCATCATCAAGTATC-3') and RACRB4-R (5'-TTTGGGCCTCTTCAGACCCAG-GTATG-3') from positions 979-1004 and 1137-1162 of the rat cDNA sequences, respectively, an amplification product was obtained that carried a polymorphic (CA), repeat (at the 3' end of intron 18 by homology with the mouse, GenBank reference U27571). The flanking sequences of the repeat were determined as reported (20) . WKY-OHD (allele size, 226 bp) and SHRSPHD (allele size, 212 bp) genotypes were determined with primers RNACRB1-F (5'-ATTGTGGGCCACTA-CATC-3') and RNACRB1-R (5'-ACAGCCATCTGTA-AGTCTAAG-3'), applying an annealing temperature of 50°C.
Na+,K+-ATPase P2 subunit (RATATPB2S) gene locus.
Comparative sequencing of PCR products that targeted the 5' flanking region of the RATATPB2S gene (21) (21)]. Amplification products were digested with 10 units of Stu I (New England Biolabs) at 37°C for 4 hr and subsequently analyzed by electrophoresis in 2.0% agarose gels.
Inducible nitric oxide synthase (RATNOSI) gene locus. Genomic DNA sequence was generated in the 5' flanking region of RATNOSI gene by using the available cDNA information (22) . Amplification with primer pairs RATNOSI-1A (5 '-CTCCTCAGGCTTGGGTCTTGTTAG-3'; positions 17-40 of the published sequence) and RATNOSI-1B (5'-GGTCACCTTGGTAGGATTTGACTC-3'; positions 131-154) generated a 1-kb fragment of genomic sequence with a polymorphic site in the parental rat strains (T in WKY-OHD and C in SHRSPHD) at position 136 of the genomic sequence (GenBank reference U27572). Genotypes were determined by allele-specific oligonucleotide hybridization. The polymorphic site was amplified by PCR using primers RATNOSI-1A and RATNOSI-2 (5'-CITCTTCCCACACCTTTCACATTAG-3'). The ASO probe (5'-TCCGCCCYGACCCTT-3') was labeled with [y-32P]ATP as described above. The PCR product was diluted in denaturing solution and applied to duplicate nylon filters (GeneScreen; New England Nuclear) on a vacuum dot blot apparatus (Scotlab, Shelton, CT) as described (23) . Prehybridization and hybridization were carried out at 41°C (23 (Fig. 1) . We termed this substrain WKY1-HD, to distinguish it from the WKYHD lineage used in earlier experiments, which we named WKY-QHD. The RNMHCG and RNNGFRR markers, at a distance of 2 cM and 20 cM from RATVAMPB in opposite directions, were identical to the WKY-OHD alleles and thus still polymorphic with respect to the corresponding SHRSPHD alleles (Fig. 1) . Additional screening of 296 SSLPs in these WKY-1HD rats revealed only one difference compared with WKY-OHD-namely, partial heterozygosity for the SHRSPHD allele at marker RCA0709 on chromosome 3. Since one of the confines of the SHRSP-homologous region in WKY-1HD localized within the previously defined 100:1 odds interval for the placement of BP/SP-1 (Fig. 1) , we hypothesized that WKY-1HD may be congenic for the SHRSPHD allele of BP/SP-1. To test this, we obtained phenotype information on the WKY-1HD strain.
Phenotype Characterization of WKY-1HD. Systolic and diastolic blood pressure values measured with radiotelemetry were significantly higher in WKY-1HD rats than in WKY-OHD rats when data were averaged over a 24-hr period both at baseline and after NaCl exposure (Table 1 ). Significant interstrain difference was also obtained when the analysis was performed separately for 12-hr periods during nighttime and daytime, respectively (data not shown).
Phenotype Characterization and Linkage Analysis in the F2 (WKY-lHD x SHRSPHD) Cross. We prepared a WKY-1HD X SHRSPHD cross to test the hypothesis that BP/SP-1, if contained within the SHRSP-homologous chromosome 10 region in WKY-1HD, would not segregate in such a cross; this would result in overall higher blood pressures and in the inability to demonstrate linkage of blood pressure to BP/SP-1. Indeed, comparison of blood pressure values between the original F2 (WKY-OHD X SHRSPHD) cross and the newly prepared F2 (WKY-1HD X SHRSPHD) cohort revealed significantly higher values in the latter among male and female animals, and before as well as after NaCl exposure (Fig. 2) .
The values for basal blood pressure in the F2 (WKY-1HD X SHRSPHD) cross were similar to those measured in the F2 (WKY-OHD X SHRSPHD) cross after NaCl loading; thus basal mean arterial blood pressures in both sexes were about 16 mmHg higher than in the F2 (WKY-OHD X SHRSPHD) cross.
At these higher baseline basal blood pressures, no differences were observed between reciprocal crosses, which is in keeping with the lack of such an effect among the original F2 (WKY-OHD X SHRSPHD) cross after NaCl exposure (10) . Moreover, as predicted by the working hypothesis, no linkage was detected between the markers on chromosome 10 that had previously exhibited significant linkage to blood pressure (9), indicating that BP/SP-1 did in fact not segregate in this cross (Fig. 2) .
Targeted Marker Development in the BP/SP-1 Region. Efforts to more precisely define the congenic region resulted in the generation and mapping of additional, specifically targeted markers on chromosome 10 (Fig. 3) . We identified two loci, RNACRB1 and RATATPB2S, that showed identical alleles in WKY-lHD and SHRSPHD but were polymorphic with WKY-OHD. Linkage analysis in the F2 (WKY-OHD X SHR-SPHD) cohort mapped these markers closely to RATVAMPB within the congenic region on chromosome 10 (Fig. 3) . In contrast, two other newly developed markers representing the RATALDCAA and RATNOSI loci were polymorphic among WKY-OHD and SHRSPHD, and identical in WKY-OHD and WKY-1HD. They are closely spaced and map 6 cM away from RNMHCG and 17 cM from RNNGFRR. This allowed us to more precisely define the size and location of the SHRSPcongenic fragment of chromosome 10 in WKY-1HD: the crossover points are localized in a 2-cM region between RNMHCG and RATRHL1/RATABPG/RATVAMPB and within a 3-cM distance between RATALDCAA and RNA-CRB1, narrowing the size of the congenic segment to a maximum of only 6 cM (Fig. 3) .
Dissection ofthe BP/SP-1 Locus into Two Components with Differential Phenotype Effects. Based on the newly established localization of the congenic region outside the previously demonstrated support interval for linkage to NaCl-induced blood pressure, but within the one defined for basal blood pressure, we reevaluated the data from the F2 (WKY-OHD X SHRSPHD) cross. Instead of using a single-locus, codominant model as in our previous study, we applied a two-locus model, assuming a dominant mode of inheritance, which we had previously demonstrated to be operative for BP/SP-1 (9) . This analysis revealed that while NaCl-loaded systolic blood pressure was strongly linked to the RNGHGP and ACE markers and mapped closely to these two genes within the previously characterized 20-cM-long odds interval (Fig. 1) , this phenotype showed no significant linkage to markers within the congenic region in WKY-lHD (Table 2 ). Conversely, basal systolic blood pressure demonstrated significant cosegregation with markers in the congenic region (Table 2) . These results suggest the existence of two, rather than one, blood pressurerelevant genes on chromosome 10 with different phenotype effects: BP/SP-la, located within the congenic segment, appears to affect primarily baseline blood pressure, whereas BP/SP-lb, located within the previously identified confidence interval for NaCl-loaded blood pressure, seems to be more significantly linked to the NaCl-induced blood pressure phenotype (Fig. 3) . The marker RCA0709 on chromosome 3, which showed partial heterozygosity for the SHRSPHD allele in WKY-1HD, exhibited no significant effect on blood pressure in either the F2 (WKY-OHD X SHRSPHD) or the F2 (WKY-1HD X SHRSPHD) cross examined.
DISCUSSION
In this report we describe a series of studies conducted to further define our earlier findings of a blood pressure-relevant locus on chromosome 10 that segregates among the SHRSP and WKY strains. The present investigation suggests that the locus previously labeled BP/SP-1 (9, 10) may in fact contain at least two separate genes, termed BP/SP-la and BP/SP-lb, that segregate independently and confer differential phenotype characteristics.
The hypothesis that the BP/SP-la locus contains a gene influencing blood pressure is supported by several observations. (i) The WKY-1HD strain, which is homologous to SHRSPHD for BP/SP-la, demonstrates significantly higher basal and NaCl-loaded blood pressure than WKY-OHD. The difference between WKY-OHD and WKY-1HD in basal blood pressure represents about 50% of the difference between WKY-OHD and SHRSPHD previously ascribed to BP/SP-1. (ii) We showed that the BP/SP-la locus was significantly linked to basal systolic and diastolic blood pressure in the F2 (WKY-OHD X SHRSPHD) cross, accounting for 24% and 22% of the variance of these phenotypes when data were analyzed adjusted for the BP/SP-lb effect and assuming a dominant model of inheritance. (iii) No linkage between the chromosome 10 region and blood pressure was detected in the F2 (WKY-lHD X SHRSPHD) cross, indicating lack of segregation of a relevant genetic locus in this cross. (iv) Overall blood pressures in the F2 (WKY-1HD X SHRSPHD) population were higher than in the F2 (WKY-OHD X SHRSPHD) cross, consistent with the postulated homozygosity of all animals for the hypertensive (SHRSP-derived) allele at BP/SP-la in the F2 (WKY-1HD X SHRSPHD) cross. The relevance of the BP/SP-lb locus, on the other hand, is supported by its linkage to NaCl-loaded' phenotypes in the F2 (WKY-OHD X. SHRSPHD) population. Cosegregation of this locus with blood pressure after NaCl exposure, although theoretically expected, was absent in the F2 (WKY-1HD X SHRSPHD) cross, suggesting a less marked phenotypic effect of BP/SP-lb on the NaCl-induced blood pressure in the presence of overall higher basal blood pressure attributed to homozygosity at BP/SP-la. Among other genetic loci previously shown to be linked to blood pressure (9, 10, 25) and tested in the F2 (WKY-1HD X SHRSPHD) cross, the SA locus on chromosome 1 (25) was found to cosegregate with blood pressure, whereas a locus on chromosome 18 for which linkage to blood pressure had previously been suggested (10) could not be confirmed (data not shown).
The genealogy of the congenic strain used in the present studies, WKY-1HD, has been reconstructed from the breeding history of the two strains SHRSPHD and WKYHD at Heidelberg. Despite the fact that the WKY-1HD strain was not deliberately bred, the origin of the introgressed chromosome 10 fragment in WKY-1HD is almost certainly from SHRSPHD, since only these two strains were maintained simultaneously in the breeding facility. This notion is furthermore confirmed by the fact that all genotypes within this region are identical to those found in SHRSPHD, whereas other strains show different alleles at these loci (data not shown). The stable, homozygous presence of the introgressed SHRSP region in WKY-1HD can be explained by a remote SHRSPHD x WKY-OHD mating, followed by successive rounds of backcrossing onto WKY prior to the initiation of strict brother/sister mating, resulting in a As in all congenic experimentation, the existence of additional genetic material derived from the "donor" strain at loci other than the targeted one is difficult to exclude. It is therefore possible that some of the effects observed in the present experiments, such as blood pressure difference among WKY-0HD and WKY-1HD or the lack of cosegregation of NaCl-loaded blood pressure with BP/SP-lb, may be related to SHRSP-congenic regions elsewhere in the WKY-1HD genome that have so far escaped our attention (due to the less than ideally even distribution of genetic markers used). Such loci may affect blood pressure either directly or by interaction with chromosome 10 loci. The magnitude of the increase in basal blood pressure in SHRSPHD X WKY-1HD hybrids over the basal pressure in rats derived from SHRSPHD X WKY-0HD may indeed be viewed as supporting this notion. However, the possible existence of other congenic loci does not distract from the relevance of the congenic chromosome 10 region that is clearly evident from the striking difference between highly significant linkage to blood pressure in one cross and complete lack thereof in the other.
The identification of BP/SP-la represents the most precise mapping of a gene contributing to hypertension reported so far in an experimental model starting from a genome screening approach (9, 10, 26) . Further work on the establishment of additional congenic lines that carry smaller subfractions of the 6-cM-long congenic chromosome 10 region will be necessary to confirm BP/SP-la and to reach a level of resolution that will make it feasible to begin physical mapping and (positional) cloning of its gene.
